Skip to main content
. 2003 Aug;89(8):897–900. doi: 10.1136/heart.89.8.897

Table 1.

Demographic data

Placebo 10 mg lexipafant 100 mg lexipafant Total
Number 50 50 50 150
Men 42 46 43 131 (87%)
Age (years) 61.9 (7.5) 62.3 (8.3) 62.4 (10.2) 62.3 (8.7)
Weight (kg) 81.5 (12.7) 85.1 (13.1) 82.6 (19.5) 83.3 (15.3)
Height (cm) 173 (9) 174 (10) 172 (10) 173 (9)
Body mass index (kg/m2) 27.3 (3.6) 28.4 (4.8) 27.7 (5.6) 27.9 (4.6)
Body surface area (m2) 1.97 (0.18) 2.01 (0.19) 1.98 (0.26) 2.0 (0.21)
Elective/urgent surgery 36/12 38/10 32/14 106/36
Aspirin (yes/no) 12/34 12/35 13/32 37/101
Number of grafts 2.8 (0.6) 2.8 (0.6) 2.7 (0.6) 2.8 (0.6)
CPB time (min) 64 (17) 65 (15) 67 (23) 65 (18)

Continuous variables are mean (SD). CPB, cardiopulmonary bypass.